BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984 AND Treatment
6 results:

  • 1. Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer.
    Dong W; Zhao H; Xiao S; Zheng L; Fan T; Wang L; Zhang H; Hu Y; Yang J; Wang T; Xiao W
    Front Immunol; 2023; 14():1263633. PubMed ID: 38149248
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. hsp90ab1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in Ovarian cancer.
    Wang D; Tang X; Ruan J; Zhu Z; Wang R; Weng Y; Zhang Y; Wang T; Huang Y; Wang H; Su Z; Wu X; Tao G; Wang Y
    Oxid Med Cell Longev; 2023; 2023():9335440. PubMed ID: 37180757
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients.
    Fei H; Chen S; Xu C
    J Ovarian Res; 2021 Mar; 14(1):41. PubMed ID: 33676525
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells.
    Giessrigl B; Krieger S; Rosner M; Huttary N; Saiko P; Alami M; Messaoudi S; Peyrat JF; Maciuk A; Gollinger M; Kopf S; Kazlauskas E; Mazal P; Szekeres T; Hengstschläger M; Matulis D; Jäger W; Krupitza G
    Hum Mol Genet; 2012 Nov; 21(21):4615-27. PubMed ID: 22843495
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy.
    Combs SE; Thilmann C; Huber PE; Hoess A; Debus J; Schulz-Ertner D
    Cancer; 2007 Jun; 109(11):2308-14. PubMed ID: 17469176
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.